Skip to content

Abcuro, Inc vs Acepodia

Abcuro, Inc logo

Abcuro, Inc

Developing immunotherapies for autoimmune diseases and cancer

43 employees · est. 2015

VS
Acepodia logo

Acepodia

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

49 employees · est. 2016 · Alameda, United States

Abcuro, Inc is the older company (2015 vs 2016).

Side-by-Side Comparison

Abcuro, Inc Acepodia
Founded
2015 older 2016
Headquarters
Not tracked yet Alameda, United States
Employees
43 49
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Series D
Total Funding
$214.85M $256.00M
Funding Rounds
5 3
Taxonomy
ImmunotherapyAutoimmune DiseasesCancer TreatmentsClinical StageAnti-KLRG1 AntibodyOrphan Drug Designation +8 AcepodiaClinical-stageCancer Cell ImmunotherapyOff-the-shelfNK CellsAntibody-cell Conjugation +7
Website
abcuro.com acepodia.com
Abcuro, Inc logo

About Abcuro, Inc

Abcuro, Inc is a clinical stage biotechnology company founded in 2015 that focuses on developing immunotherapies for autoimmune diseases and cancer. The company is known for its flagship products ABC008 and ABC015, both of which target cytotoxic T and NK cells expressing the inhibitory immune checkp...

Acepodia logo

About Acepodia

Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its An...

Also comparing in this category

Comparing more than these two?

Get Abcuro, Inc, Acepodia and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Abcuro, Inc compare?

A PDF of Abcuro, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Abcuro, Inc was founded in 2015, with 43 employees. Abcuro, Inc is a clinical stage biotechnology company founded in 2015 that focuses on developing immunotherapies for autoimmune diseases and cancer. The company is known for its flagship products ABC0. Acepodia was founded in 2016, based in Alameda, United States, with 49 employees. Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCE.
Abcuro, Inc has raised $214.85M and Acepodia $256.00M. Latest stage: Abcuro, Inc Series B, Acepodia Series D.
Both work in Biotechnology, Health Care and Health and Wellness and list nk cells among their focus areas.

Compare Abcuro, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Abcuro, Inc on 11 Sep 2024, and Acepodia on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout